Dubai: The Ministry of Health and Prevention has signed two agreements with Pfizer Gulf Pharmaceutical Company to provide free medications to 90 patients with breast, lung, kidney and other cancers treated with Pfizer medications.
The agreements will also provide free medications for 120 patients with rheumatoid arthritis, who qualify for the initiative, for one year. This will be in keeping with the treatment plan and the doctors’ prescriptions.
The agreements come in line with the Year of Zayed (2018) initiatives.
The signing ceremony was held at the ministry’s headquarters in Dubai, in the presence of Dr Ameen Al Amiri, the ministry’s assistant undersecretary for public health policy and licensing sector; and Mohammad Fawzi, cluster lead for Pfizer in the Gulf region.
Dr Al Amiri said: “Our aim is to improve the quality of health services for all patients in the UAE, and to enhance the community’s happiness. We also work towards improving treatment outcomes by increasing patients’ commitment to the prescribed treatment, supporting uninsured patients and financially challenged patients who lack prescription coverage for their treatments. The initiatives will also benefit patients with partial insurance coverage or none at all.”
He said the expected results of the two initiatives will ensure appropriate treatment for qualified patients through sustainable solutions that ensure the continuity of access of patients to medicines according to the treatment plan.
Fawzy said the agreements complement Pfizer’s commitment to the Year of Zayed and come within the framework of social responsibility to support the efforts of the ministry in improving the quality of patients’ life.
Al Amiri explained that the role of Axios and MGG will enhance coordination with charities and NGOs recognised by the UAE as strategic partners to organise and implement this programme.